Clinical Trial Update: Vascular Complications in Patients Undergoing Peripheral Revascularization and Taking SGLT-2 Inhibitors

View source ↗

Summary

A ClinicalTrials.gov entry notes a study evaluating whether SGLT-2 inhibitors impact vascular complications after peripheral revascularization in patients with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Disease

Drugs mentioned

• Canagliflozin (canagliflozin)
• Dapagliflozin (dapagliflozin)
• Empagliflozin (empagliflozin)
• Ertugliflozin (ertugliflozin)

Snippet

Sponsor: Wroclaw Medical University | Conditions: Peripheral Arterial Disease(PAD) | Status: RECRUITING